The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing for levonorgestrel on the Prescription Drug List (PDL). Only the Human part of the PDL was revised; the listing for Veterinary use will remain unchanged.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Notice - Prescription Drug List (PDL): LevonorgestrelHTMLEnglish publication HTML
-
Notice - Prescription Drug List (PDL): LevonorgestrelHTMLFrench publication HTML
Similar records